why choose us

Clinical Trials Search

Showing 17,600 of 132,963 result(s)
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

Status: Completed

Condition: Metabolic Syndrome

Interventions: Up-titration will be performed as guided by the evaluation of blood pressure and clinical symptoms

Date: 2022-12-06

A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

Status: Completed

Condition: Uveitic Macular Edema

Interventions: Participants will receive vamikibart IVT injection

Date: 2022-12-06

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

Status: Completed

Condition: HCV

Interventions: For participants enrolled in P2W arm, the initial dose of SOF;VEL will be administered to the recipient when called to the operating room for tra

Date: 2022-12-06

Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab

Status: Completed

Condition: Leukemia, Lymphocytic, Chronic, B-Cell

Interventions: 320 mg once per day by mouth

Date: 2022-12-06

Janus Kinase Inhibition in Granuloma Annulare

Status: Completed

Condition: Granuloma Annulare

Interventions: Abrocitinib (Cibinqo) is FDA approved at 200 mg dose once daily for the treatment of atopic dermatitis.
It is not currently FDA approved for the

Date: 2022-12-06

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: Intravenous Infusion

Date: 2022-12-06

Use of Ritual Prenatal Multivitamins for Pregnancy

Status: NOT_YET_RECRUITING

Condition: Pregnancy Related

Interventions: The Ritual Epre supplement uses methyl folate instead of folic acid and has higher vitamin D and biotin contents compared to the control supplement.

Date: 2022-12-06

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine

Status: Completed

Condition: Migraine

Interventions: The Thermal Sensory Analyzer (TSA-II or PATHWAY platform - Medoc, Ramat Yishai, Israel) will be used to safely deliver heat and cold stimuli.
The

Date: 2022-12-06

Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study

Status: Completed

Condition: Breast Cancer

Interventions: A personalized lifestyle counseling programme.

Date: 2022-12-06

Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

Status: Completed

Condition: Retinal Disease

Interventions: Patients will receive Fluorescein Sodium 3mL (300mg) or 1mL (100mg) intravenously prior to fluorescein angiography.

Date: 2022-12-06